Question 1

What are the different markets in which
        Biologics LIMS and
        Montrium compete against each other?

Accepted Answer

Biologics LIMS and
        Montrium compete against each other in
        the Clinical Trial Management System (CTMS).

Question 2

How does the market share of
        Biologics LIMS
        and Montrium compare in the
        Clinical Trial Management System (CTMS) market?

Accepted Answer

In the Clinical Trial Management System (CTMS) market,
        Biologics LIMS has a
        21.48%
        market share in comparison to
        Montrium’s
        4.33%.
        Since it has a better market share coverage,
        Biologics LIMS holds the
        2nd
        spot in 6sense's Market Share Ranking Index for
        the Clinical Trial Management System (CTMS) category, while
        Montrium holds the
        8th spot.

Question 3

How many customers are acquired by
        Biologics LIMS and
        Montrium in the
        Clinical Trial Management System (CTMS) segment?

Accepted Answer

Biologics LIMS has
        119 customers and
        Montrium has
        24 customers in the
        Clinical Trial Management System (CTMS)
        segment. Biologics LIMS has
        95 more customers than
        Montrium in this category.

Question 4

What are the countries in which
        Biologics LIMS and
        Montrium has more customers?

Accepted Answer

Biologics LIMS has more customers in United States, United Kingdom and Germany.
Montrium has more customers in United States, Canada and Netherlands.

Biologics LIMS Vs Montrium : In-Depth Comparison

Choose Technologies to compare

Comparing the customer bases of Biologics LIMS and Montrium

Comparing the market share of Biologics LIMS and Montrium

Compare Biologics LIMS vs Montrium customers by geography

Customer Movements for this month

FAQ

Choose Technologies to compare

Save 15 hours a week on sales research

Get instant access to B2B contact data across the web

Company

Browse 6sense Data